Exploiting the defensive sugars of HIV-1 for drug and vaccine design
The sustained effort towards developing an antibody vaccine against HIV/AIDS has provided much of our understanding of viral immunology. It is generally accepted that one of the main barriers to antibody neutralization of HIV is the array of protective structural carbohydrates that covers the antige...
Κύριοι συγγραφείς: | Scanlan, C, Offer, J, Zitzmann, N, Dwek, R |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Nature Research
2007
|
Παρόμοια τεκμήρια
-
Emerging principles for the therapeutic exploitation of glycosylation.
ανά: Dalziel, M, κ.ά.
Έκδοση: (2014) -
Sugar immunogens
ανά: Dwek, R, κ.ά.
Έκδοση: (2009) -
Antigenic mimicry of the HIV envelope by AIDS-Associated pathogens
ανά: Dunlop, D, κ.ά.
Έκδοση: (2008) -
Antigenic mimicry of the HIV envelope by AIDS-associated pathogens.
ανά: Dunlop, D, κ.ά.
Έκδοση: (2008) -
Yeast mannan genetics controls the molecular specificity of anti-carbohydrate antibodies cross-reactive to the HIV envelope
ανά: Dunlop, D, κ.ά.
Έκδοση: (2009)